Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 27, 2017
What are the generic sources for desipramine hydrochloride and what is the scope of desipramine hydrochloride patent protection?
Desipramine hydrochloride is the generic ingredient in three branded drugs marketed by Sandoz, Actavis Totowa, Ani Pharms Inc, Amneal Pharms Co, Sanofi Aventis Us, Heritage Pharms Inc, Impax Labs Inc, Usl Pharma, and Us Pharm Holdings, and is included in twenty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 3 |
| Patents: | 1 |
| Applicants: | 9 |
| NDAs: | 21 |
| Drug Master File Entries: see list | 9 |
| Suppliers / Packagers: see list | 15 |
| Bulk Api Vendors: see list | 37 |
| Clinical Trials: see list | 2,297 |
| Patent Applications: see list | 1,571 |
| Therapeutic Class: | Antidepressants |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | desipramine hydrochloride at DailyMed |
| Drug Class | Tricyclic Antidepressant |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Totowa | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 071601-001 | Jun 5, 1987 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Impax Labs Inc | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 205153-006 | Oct 28, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Actavis Totowa | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 071588-001 | Jun 5, 1987 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Heritage Pharms Inc | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 207433-002 | May 5, 2016 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Sandoz | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 072104-001 | Jun 20, 1988 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Us Pharm Holdings | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-005 | Approved Prior to Jan 1, 1982 | 3,454,698 | ► Subscribe | ||||||||||||||||||||||
Us Pharm Holdings | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-006 | Approved Prior to Jan 1, 1982 | 3,454,554 | ► Subscribe | ||||||||||||||||||||||
Sanofi Aventis Us | PERTOFRANE | desipramine hydrochloride | CAPSULE;ORAL | 013621-002 | Approved Prior to Jan 1, 1982 | 3,454,698 | ► Subscribe | ||||||||||||||||||||||
Us Pharm Holdings | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-004 | Approved Prior to Jan 1, 1982 | 3,454,554 | ► Subscribe | ||||||||||||||||||||||
Us Pharm Holdings | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-007 | Feb 11, 1982 | 3,454,698 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,716 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
